Can Tessalon (benzonatate) pearls and guaifenesin be administered through a feeding tube?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Tessalon Pearls (Benzonatate) and Guaifenesin Administration via Feeding Tube

Tessalon pearls (benzonatate) should NEVER be administered through a feeding tube, while guaifenesin can be given via feeding tube but will lose its therapeutic effect.

Benzonatate (Tessalon Pearls): Contraindicated

The FDA labeling explicitly warns that benzonatate capsules must be swallowed whole and must not be broken, chewed, dissolved, cut, or crushed 1. This is a critical safety issue because:

  • Release of benzonatate in the mouth produces temporary local anesthesia of oral mucosa and can cause choking 1
  • The drug is chemically related to local anesthetics (procaine, tetracaine) and premature release causes dangerous CNS effects 1
  • Accidental ingestion has resulted in death in children, with symptoms appearing within 15-20 minutes and death within one hour 1
  • Overdose can cause restlessness, tremors, convulsions, coma, and cardiac arrest 1

Alternative approach: Consult with the prescribing physician and pharmacist to identify an alternative antitussive that can be safely administered via feeding tube 2. The soft gelatin capsule formulation of benzonatate is incompatible with feeding tube administration.

Guaifenesin: Technically Possible but Therapeutically Ineffective

While guaifenesin can physically be administered through a feeding tube (liquid formulations exist), it will not work as an expectorant via this route. Research demonstrates that:

  • Guaifenesin's expectorant action is mediated by reflex stimulation of the gastric mucosa, NOT by systemic absorption 3
  • Intravenous administration produced 1.5-fold higher systemic exposure than oral administration but did NOT increase respiratory secretions 3
  • The drug requires contact with the upper GI tract (specifically gastric mucosa) to trigger the vagal reflex that stimulates respiratory secretions 3

Clinical implication: If the feeding tube terminates in the stomach (gastric tube), guaifenesin liquid may retain some efficacy. However, if the tube is post-pyloric (jejunal), the drug will be completely ineffective as an expectorant despite adequate absorption 3.

General Feeding Tube Medication Administration Principles

When evaluating ANY medication for feeding tube administration 2:

  1. Confirm necessity and appropriateness - Consider the tube tip location and whether drug efficacy can be maintained 2
  2. Consult pharmacist involvement - This is strongly recommended for all feeding tube medication decisions 2
  3. Never crush sustained-release, enteric-coated, or soft gelatin capsules 2
  4. Administer drugs individually - Flush with 30 mL water before, between, and after each medication 2, 4
  5. Check for drug-formula interactions - Some medications bind to enteral formula and require administration apart from feeding 2

Common Pitfalls to Avoid

  • Assuming oral medications can automatically be given via tube - Many require specific formulations or are contraindicated 5, 6
  • Mixing multiple medications together - This increases risk of drug-drug interactions and tube occlusion 2
  • Inadequate flushing - Use at least 30 mL water to prevent tube blockage 2, 4
  • Ignoring tube tip location - Gastric vs. jejunal placement significantly affects drug absorption and efficacy 2, 4

Bottom line: For this patient, discontinue both medications and work with the pharmacist to identify appropriate alternatives that are both safe and effective when administered via the specific type of feeding tube in place.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.